创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels: The Advantages of Homologous Modeling

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-02-23 15:08
  • Views:

(Summary description)In the field of medical research, InnoModels Biotechnology has made great breakthroughs with its homology modeling technology. This technology provides scientists with a new way to better understand the mechanisms of disease, accelerate the drug discovery process, and enable personalized medicine

InnoModels: The Advantages of Homologous Modeling

(Summary description)In the field of medical research, InnoModels Biotechnology has made great breakthroughs with its homology modeling technology. This technology provides scientists with a new way to better understand the mechanisms of disease, accelerate the drug discovery process, and enable personalized medicine

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-02-23 15:08
  • Views:
Information

In the field of medical research, InnoModels Biotechnology has made great breakthroughs with its homology modeling technology. This technology provides scientists with a new way to better understand the mechanisms of disease, accelerate the drug discovery process, and enable personalized medicine. The following are the advantages of InnoModels' bio-homologous models:
1. Mimic human physiology
Homologous modeling technology allows scientists to use human cells to construct models that mimic the physiological characteristics of the human body. Compared with animal models, these homologous models can more accurately reflect the internal biological processes of the human body, which is more helpful in predicting the effects of drugs on the human body as well as the mechanisms of disease development.
2. Improving the accuracy of disease research
Homologous modeling technology allows researchers to build models of specific diseases, such as cancer and genetic diseases. These models can not only more accurately simulate the physiological and pathological processes of diseases, but can also be used to assess the effectiveness of potential treatments, providing important support for the development of precision medicine.
3. Realization of personalized medicine
Homologous model technology provides a new way to realize personalized medicine. By using patients' cells, scientists can construct models that match patients' biological characteristics, thus providing patients with personalized treatment plans and predicting the efficacy and side effects of specific treatments.

 


4. Accelerating the drug discovery process
The use of homology models for drug screening and toxicity testing can greatly accelerate the drug development process. Compared to traditional animal testing, homology models are more predictive and reliable, providing more accurate assessments of efficacy and toxicity and reducing the time and cost of drug development.
5. Enhancing the feasibility of alternative methods
With increasing concerns about the ethics and cost of animal testing, homologous modeling techniques offer a viable option for finding alternative methods. This technique not only reduces the reliance on animal experiments, but also improves the reproducibility and reliability of experimental results, thus promoting the development and application of alternative methods.
Conclusion
Homologous modeling technology of InnoModels provides scientists with a more accurate and reliable research tool by simulating human physiological characteristics and disease processes, which promotes the development of drug discovery, disease treatment and personalized medicine. With the continuous progress and innovation of the technology, it is believed that homology modeling technology will play an increasingly important role in the future and bring more breakthroughs for human health.

Keyword:

In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
In the vast field of drug discovery and life science research, InnoModels Biotechnology (Beijing) Co., Ltd. is gradually becoming a leader in the industry with its IC50 platform. The platform not only integrates advanced detection technologies, abundant cell resources and strict quality control system, but also provides researchers with efficient and reliable experimental solutions through continuous innovation and optimization.
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司